Nasometry Devices Market is Anticipated to Witness Steady Growth Due to Rising Prevalence of Respiratory Diseases
![]() |
Nasometry Devices Market |
Nasometry
devices are medical instrument used to objectively measure the acoustic
characteristics of nasal air flow during respiration. These devices provide
valuable insight into nasal function, congestion, and resistance. The rising
prevalence of respiratory diseases such as sinusitis, sleep apnoea, and
allergic rhinitis has increased the demand for nasometry devices globally.
These conditions require proper diagnosis and monitoring to develop an
effective treatment plan. Nasometry devices offer non-invasive solutions to
accurately assess nasal patency, congestion levels, and response to treatment.
The Global
Nasometry devices Market Demand is estimated to be valued at US$ 336.9
Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period
2024 to 2031.
Key Takeaways
Key players operating in the Nasometry Devices are GM Instruments Ltd., Rose
Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates,
Inc., Medtronic, Homoth Medizinelektronik, Recorders & Medicare Systems
Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical,
Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises
Incorporated, and Vivos Therapeutics Inc. These players are focusing on new
product launches and partnerships to expand their global presence.
Growing awareness regarding the clinical benefits of nasometry devices in
assessing nasal symptoms, congestion levels, and treatment responses
noninvasively is creating lucrative opportunities for players. Furthermore,
rising demand for remote monitoring and diagnosis of respiratory conditions
amid the COVID-19 pandemic is augmenting the demand for home-use nasometry
devices.
The major players are actively engaging in strategic deals such as acquisitions
and partnerships with local players to strengthen their international foothold.
For instance, in September 2021, GM Instruments Ltd. partnered with Azad
Scientific to distribute its range of nasometry products including Nasometer II
in the Middle East and North African markets. Such initiatives are helping
companies expand globally.
Market drivers:
- Increasing prevalence of respiratory diseases such as sinusitis, rhinitis,
and sleep apnea is a key growth driver. As per European Respiratory Society,
over 1 billion people suffer from chronic sinusitis globally. This vast patient
pool is driving the need for accurate diagnosis using nasometry devices.
- Rising awareness about the technology and clinical benefits of objective
assessment of nasal congestion is encouraging more ENT specialists and
allergists to adopt nasometry equipment in their practice.
Market restraints:
- High cost of advanced nasometry devices limits their adoption in primary care
settings and developing regions with budget constraints in the healthcare
system. This acts as a major barrier.
- Lack of reimbursement policies for nasometry procedures in many countries
hinders market growth. Most private payers do not cover insurance claims for
the procedure limiting affordability.
Segment
Analysis
The nasometry devices market is dominated by clinical laboratories and
hospitals sub segment. This is because most of the major players provide
devices that are mostly suitable for clinical use and diagnostic purpose. These
nasometry devices help ENT specialists and other physicians to accurately
diagnose a range of conditions affecting the nasal cavity such as nasal
obstruction, deviated nasal septum or nasal polyps. The devices provide
objective measures of nasal airflow and resistance. These clinical grade
devices are fairly expensive but provide reproducible and reliable results.
Home use nasometry devices sub segment is emerging owing to innovations
facilitated by new players. These home use devices are affordably priced and
allow self monitoring of nasal patency which is especially useful for athletes
and performers.
Global Analysis
North America region dominated the global nasometry devices market in 2024 with
over 40% share. This is attributed to growing awareness about nasal disorders,
established healthcare infrastructure and reimbursement scenarios. Moreover,
presence of leading players in the US contribute to the large share of the
region. Europe was the second largest market for nasometry devices in 2024 due
to major technological advancements from Germany, UK and Nordic nations. Asia
Pacific region is anticipated to witness the fastest growth over the forecast
period of 2024 to 2031 backed by increasing medical tourism, rising awareness
and improving healthcare infrastructure in developing countries such as India and
China. Latin America and Middle East & Africa provide considerable growth
opportunities for players due to rising disposable incomes and healthcare
expenditure.
For
more insights, Read- Nasometry
Devices Market
Comments
Post a Comment